Esophageal Cancer: Japan Approves Telomelysin, a World-First Tumor-Killing Virus Drug
Telomelysin, a common-cold virus reprogrammed to destroy cancer cells, has won the world's first approval for esophageal cancer. It took 35 years, one surgeon's idea, and an Okayama University startup pushing through a regulatory maze.